Parallax Volatility Advisers’s Ionis Pharmaceuticals IONS Stock Holding History

Parallax Volatility Advisers’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,900	Closed	-$477K	–	2171
2024 Q3	$477K	Sell	11,900 -49,700	-81%	-$2.31M	﹤0.01%	1534
2024 Q2	$2.94M	Buy	+61,600	New	+$2.53M	0.01%	900
2022 Q4	–	Sell	-5,200	Closed	-$230K	–	3065
2022 Q3	$230K	Buy	+5,200	New	+$219K	﹤0.01%	2273
2022 Q1	–	Sell	-42,800	Closed	-$1.3M	–	2928
2021 Q4	$1.3M	Hold	42,800	–	–	﹤0.01%	1196
2021 Q3	$1.44M	Buy	+42,800	New	+$1.61M	﹤0.01%	1226
2019 Q2	–	Sell	-5,000	Closed	-$406K	–	3148
2019 Q1	$406K	Buy	5,000 +4,800	+2,400%	+$310K	﹤0.01%	1608
2018 Q4	$11K	Buy	+200	New	+$10.2K	﹤0.01%	2488
2018 Q3	–	Sell	-20,000	Closed	-$833K	–	3075
2018 Q2	$833K	Buy	+20,000	New	+$887K	﹤0.01%	1143
2017 Q4	–	Sell	-18,000	Closed	-$913K	–	4431
2017 Q3	$913K	Buy	+18,000	New	+$943K	﹤0.01%	1105

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Parallax Volatility Advisers's IONS Position: Q3 2024 in Review

Parallax Volatility Advisers sold out of Ionis Pharmaceuticals (IONS) in Q3 2024, closing a stake of 12,310 shares — an estimated $573K sold.

Parallax Volatility Advisers first reported a position in IONS in Q2 2015 and held it in 6 quarters. The position peaked at $1.11M in Q2 2015. 353 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

Parallax Volatility Advisers reported no remaining Ionis Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Parallax Volatility Advisers sold 12,310 Ionis Pharmaceuticals shares in Q3 2024, an estimated $573K.
Parallax Volatility Advisers first reported a position in Ionis Pharmaceuticals in Q2 2015 and held it in 6 quarters.
Parallax Volatility Advisers's Ionis Pharmaceuticals position peaked at $1.11M in Q2 2015.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on Parallax Volatility Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.